Characteristics | Regional hosp (n = 30) | General hosp (n = 180) | H/center (n = 60) | Total (N = 270) | χ2(2*) | P-value |
---|---|---|---|---|---|---|
WHO stage | 16 (53.3%) | 178 (98.9%) | 60 (100.0%) | 254 (94.1%) | 100.59 | <0.001 |
CD4 count | 29 (96.7%) | 114 (63.3%) | 32 (53.3%) | 175 (64.8%) | 17.0 | < 0.001 |
Basic lab tests | 23 (76.7%) | 76 (42.2%) | 22 (36.7%) | 121 (44.8%) | 14.4 | 0.001 |
Prescribed preferred 1st line ARV regimen (AZT/3TC/NVP or EFV) | 28 (93.3%) | 126 (70.0%) | 32 (53.3%) | 186 (68.9%) | 15.24 | <0.001 |